Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
CANO.WS was delisted on the 9th of November, 2023.
33 hedge funds and large institutions have $42.6M invested in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.
150% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 4
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
18% more funds holding
Funds holding: 28 → 33 (+5)
45% less capital invested
Capital invested by funds: $77.2M → $42.6M (-$34.6M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
+$1.14M |
| 2 |
ICM
Ionic Capital Management
New York
|
+$643K |
| 3 |
CL
CSS LLC
Chicago,
Illinois
|
+$307K |
| 4 |
ACM
Aljian Capital Management
Carson City,
Nevada
|
+$190K |
| 5 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$164K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$3.91M |
| 2 |
LP
LMR Partners
London,
United Kingdom
|
-$2.28M |
| 3 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
-$1.94M |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$413K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$162K |
CANO.WS Hedge Fund Activity: Q4 2021 in Review
33 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) for Q4 2021, worth a combined $42.6M — down 45% from $77.2M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new CANO.WS positions and 4 closed out — a net gain of 6 holders — while 6 added to existing stakes and 4 trimmed.
The largest buyer was Walleye Capital, adding an estimated $1.14M. The largest seller was Mangrove Partners, exiting entirely with an estimated $3.91M sold.
- 33 institutional investors held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) as of Q4 2021, up from 28 in Q3 2021.
- Funds reported $42.6M of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 stock for Q4 2021, down 45% quarter-over-quarter.
- 10 funds opened new Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 positions in Q4 2021 and 4 closed out, a net change of +6 holders.
- The largest Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 buyer in Q4 2021 was Walleye Capital, an estimated $1.14M added.
- The largest Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 seller in Q4 2021 was Mangrove Partners, an estimated $3.91M sold.
Based on aggregated 13F filings for Q4 2021.